Unilateral Macular Choroidal Neovascularization; a Rare Manifestation in Chronic Myelogenous Leukemia

PURPOSE: To report a case of chronic myelogenous leukemia (CML) treatment with imatinib mesylate in the remission phase who developed unilateral macular choroidal neovascularization (CNV). METHODS: A 45-year-old male marketer with a 5-year history of CML treated with imatinib mesylate presented with...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Curr Ophthalmol
Egile Nagusiak: Pour, Elias Khalili, Bazvand, Fatemeh, Mehrabi Bahar, Mohammad Reza, Abadi, Mahmood Davood, Faghihi, Hooshang
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Wolters Kluwer - Medknow 2020
Gaiak:
Case Report
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7265268/
https://ncbi.nlm.nih.gov/pubmed/32510022
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.joco.2019.09.003
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak